Genpharmasec Ltd
BSE:531592
Intrinsic Value
The intrinsic value of one GENPHARMA stock under the Base Case scenario is 0.82 INR. Compared to the current market price of 2.14 INR, Genpharmasec Ltd is Overvalued by 62%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Genpharmasec Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Genpharmasec Ltd
Balance Sheet Decomposition
Genpharmasec Ltd
Current Assets | 217m |
Cash & Short-Term Investments | 38.2m |
Receivables | 58.3m |
Other Current Assets | 120.5m |
Non-Current Assets | 536.8m |
Long-Term Investments | 194m |
PP&E | 63m |
Other Non-Current Assets | 279.8m |
Free Cash Flow Analysis
Genpharmasec Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Genpharmasec Ltd
Revenue
|
299.1m
INR
|
Cost of Revenue
|
-237.6m
INR
|
Gross Profit
|
61.5m
INR
|
Operating Expenses
|
-56.5m
INR
|
Operating Income
|
5m
INR
|
Other Expenses
|
10.4m
INR
|
Net Income
|
15.5m
INR
|
GENPHARMA Profitability Score
Profitability Due Diligence
Genpharmasec Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
Score
Genpharmasec Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.
GENPHARMA Solvency Score
Solvency Due Diligence
Genpharmasec Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Score
Genpharmasec Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GENPHARMA Price Targets Summary
Genpharmasec Ltd
Dividends
Current shareholder yield for GENPHARMA is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one GENPHARMA stock under the Base Case scenario is 0.82 INR.
Compared to the current market price of 2.14 INR, Genpharmasec Ltd is Overvalued by 62%.